# Evaluation of Venous Thromboembolism Prevention in High-Risk Trauma Patients

> **NCT02412982** · PHASE4 · COMPLETED · sponsor: **University of Cincinnati** · enrollment: 103 (actual)

## Conditions studied

- Traumatic Injury
- Venous Thromboembolism

## Interventions

- **DRUG:** Enoxaparin 40 mg q12h
- **DRUG:** Enoxaparin 30 mg q8h

## Key facts

- **NCT ID:** NCT02412982
- **Lead sponsor:** University of Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2019-01
- **Final completion:** 2019-01
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2021-10-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02412982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02412982, "Evaluation of Venous Thromboembolism Prevention in High-Risk Trauma Patients". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02412982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*